Literature DB >> 15328425

Intermittent elevation of serum urate and 24-hour urinary uric acid excretion.

K-H Yu1, S-F Luo, W-P Tsai, Y-Y Huang.   

Abstract

OBJECTIVES: Serum urate concentrations fluctuate throughout the day, and may be subject to variation with time. However, monthly variation of urinary uric acid excretion has not been investigated. This prompted us to investigate serum urate and 24-h urinary uric acid excretion in healthy men.
METHODS: Serum urate and creatinine and 24-h urinary uric acid and creatinine were measured at monthly intervals throughout a 12-month period in 12 healthy men (aged 23-61 yr) from July 2002 to June 2003.
RESULTS: The mean age of the 12 healthy men was 35.3+/-10.5 yr (median 33, range 23-61), and they had mean serum urate concentration 7.1+/-1.1 mg/dl (range 4.6-10.4), mean serum creatinine 1.0+/-0.1 mg/dl (range 0.8-1.3) and mean 24-h urinary uric acid excretion 651+/-189 mg/day/1.73 m(2) (median 623, range 389-1565). Approximately 20.1 and 20.7% of the measurements displayed above normal serum urate level and daily urinary uric acid excretion of more than 800 mg, respectively.
CONCLUSIONS: The data presented here demonstrate individual variations in serum urate levels and 24-h urinary uric acid excretions in healthy men with serial measurement. Transient hyperuricaemia and hyperuricosuria are more common than expected, and both transitory and monthly variations are important factors to consider when evaluating the influence of other factors upon serum urate levels and urinary uric acid excretion. Further studies are needed to confirm these results using larger populations.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15328425     DOI: 10.1093/rheumatology/keh379

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  9 in total

1.  Indirect pharmacodynamic models for responses with circadian removal.

Authors:  Vivaswath S Ayyar; Wojciech Krzyzanski; William J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2019-01-29       Impact factor: 2.745

2.  Genotype-based changes in serum uric acid affect blood pressure.

Authors:  Afshin Parsa; Eric Brown; Matthew R Weir; Jeffrey C Fink; Alan R Shuldiner; Braxton D Mitchell; Patrick F McArdle
Journal:  Kidney Int       Date:  2011-12-21       Impact factor: 10.612

3.  No evidence for a causal link between uric acid and type 2 diabetes: a Mendelian randomisation approach.

Authors:  R Pfister; D Barnes; R Luben; N G Forouhi; M Bochud; K-T Khaw; N J Wareham; C Langenberg
Journal:  Diabetologia       Date:  2011-06-30       Impact factor: 10.122

4.  Influence of urate-lowering therapies on renal handling of uric acid.

Authors:  Lili Ma; Lei Wei; Huiyong Chen; Zhuojun Zhang; Qiang Yu; Zongfei Ji; Lindi Jiang
Journal:  Clin Rheumatol       Date:  2014-11-06       Impact factor: 2.980

5.  Common variants in SLC17A3 gene affect intra-personal variation in serum uric acid levels in longitudinal time series.

Authors:  Ozren Polasek; Iris Jeroncić; Rosanda Mulić; Zorana Klismanic; Marina Pehlić; Tatijana Zemunik; Ivana Kolcić
Journal:  Croat Med J       Date:  2010-02       Impact factor: 1.351

6.  Uric acid and dementia in community-dwelling older persons.

Authors:  Carmelinda Ruggiero; Antonio Cherubini; Fulvio Lauretani; Stefania Bandinelli; Marcello Maggio; Angelo Di Iorio; Giovanni Zuliani; Charalampos Dragonas; Umberto Senin; Luigi Ferrucci
Journal:  Dement Geriatr Cogn Disord       Date:  2009-04-01       Impact factor: 2.959

Review 7.  Serum uric acid and acute kidney injury: A mini review.

Authors:  Kai Hahn; Mehmet Kanbay; Miguel A Lanaspa; Richard J Johnson; A Ahsan Ejaz
Journal:  J Adv Res       Date:  2016-09-24       Impact factor: 10.479

8.  Potent human uric acid transporter 1 inhibitors: in vitro and in vivo metabolism and pharmacokinetic studies.

Authors:  Michael F Wempe; Janet W Lightner; Bettina Miller; Timothy J Iwen; Peter J Rice; Shin Wakui; Naohiko Anzai; Promsuk Jutabha; Hitoshi Endou
Journal:  Drug Des Devel Ther       Date:  2012-11-08       Impact factor: 4.162

9.  Hyperuricemia and incident cardiovascular disease and noncardiac vascular events in patients with rheumatoid arthritis.

Authors:  Daniel Kuo; Cynthia S Crowson; Sherine E Gabriel; Eric L Matteson
Journal:  Int J Rheumatol       Date:  2014-08-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.